FDA Chides Alvogen Over Black Box Omission
Generic-drug maker Alvogen Inc. flouted federal law by distributing sales literature that failed to mention the limited effectiveness and black box warning associated with the alcoholism medication disulfiram, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article